標普和納斯達克內在價值 聯繫我們
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← 返回所有股票

Bayer AG BAYRY OTC

Other OTC • Healthcare • Drug Manufacturers - General • DE • USD

SharesGrow Score
33/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Bayer AG (BAYRY) 是一家 制药 - 綜合 公司，屬於 醫療保健 產業, 目前交易價格為 $11.90. 其SharesGrow評分為 32/100, 表明 較弱 的投資特徵， 7項中通過1項.

財務數據: 營收為 $43.8B, -4.8%/yr 平均成長. 淨利潤為 $3.5B (虧損), 成長率為 -64.6%/yr. 淨利潤率為 -7.9% (負值). 毛利率為 59.2% (-1.6 pp 趨勢).

資產負債表: 總債務為 $37.4B 對比 $25.9B 股東權益 (D/E比率 1.44, 適度). 流動比率為 1 (充足). 資產負債率為 33.9%. 總資產: $110.6B.

分析師展望: 1 / 3 位分析師評級 BAYRY 為買入 (33%) — 意見分歧.

SharesGrow 7項標準細分: Value ?/100 (Fail), Growth 15/100 (Fail), Past 25/100 (Fail), Health 50/100 (Partial), Moat 80/100 (Pass), Future 20/100 (Fail), Income 10/100 (Fail).

BAYRY SharesGrow 評分概覽

33/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
價值 0/100
估值 — P/E, PEG, Forward PEG
成長 15/100
財務數據 — 平均成長
過去 25/100
強勁 — 趨勢
健康 50/100
資產負債表 — D/E比率, 流動比率為
護城河 80/100
毛利率為 + market cap
未來 20/100
分析師展望 — 為買入
收入 10/100
淨利潤率為
Scores derived from financial statements, analyst ratings, and balance sheet data.

評分明細 — BAYRY

—
價值 N/A
N/A
No analyst coverage available for this stock.
✗
成長 Fail
15/100
BAYRY: -4.8%/yr 營收為, -64.6%/yr 淨利潤為 平均成長. 較弱. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
過去 Fail
25/100
BAYRY: 1 / 4 年獲利. 較弱. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
~
健康 Partial
50/100
資產負債表 BAYRY: D/E比率 1.44 (適度), 流動比率為 1 (充足). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✓
護城河 Pass
80/100
BAYRY: 毛利率為 59.2% (-1.6 pp 趨勢), $47B market cap. Moat (0-100): margin (35%) + 趨勢 (15%) + market cap (30%) + 營收為 (20%). Score 80/100. ≥ 70 = Pass.
View details →
✗
未來 Fail
20/100
分析師展望: 1 / 3 位分析師評級 BAYRY 為買入 (33%). Score: 60% buy consensus + 40% 上漲空間. ≥ 60 = Pass.
View details →
✗
收入 Fail
10/100
BAYRY: 淨利潤率為 -7.9%. 負值. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

市場數據
52週區間5.3-14.85
成交量167.2K
30日平均成交量1.55M
市值$46.76B
Beta（1年）0.89
股息率$0.0300
Share Statistics
EPS（TTM）-0.88
流通股數$3.93B
IPO Date1996-11-18
Employees90,587
CEOWilliam N. Anderson
Financial Highlights & Ratios
Revenue (TTM)$43.78B
Gross Profit$25.92B
EBITDA$10.57B
Net Income$-3.48B
Operating Income$6.68B
Total Cash$7.85B
Total Debt$37.43B
Net Debt$30.76B
Total Assets$110.56B
Price / Earnings (P/E)-13.5
Price / Sales (P/S)1.07
Analyst Forecast
評級共識Hold
覆蓋分析師數3
買入 33% 持有 67% 賣出 0%
公司資訊
國家DE
交易所Other OTC
貨幣USD
ISINUS0727303028

股價走勢

Track all markets on TradingView
BAYRY
Bayer AG ↗  ·  Other OTC
Healthcare • Drug Manufacturers - General
5.30 52WK RANGE 14.85

其他人也在看

RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
 NVS
NVS
Novartis AG
$153.38
-0.71%
 GILD
GILD
Gilead Sciences, Inc.
$140.45
+1.02%
 GSK
GSK
GSK plc
$59.18
+0.41%
 BMY
BMY
Bristol-Myers Squibb Company
$58.08
+0.03%
 SNY
SNY
Sanofi
$47.64
+1.45%
聯繫我們
🎓
SharesGrow 學院
學習如何計算內在價值，發現被低估的股票。
每週線上課程
📧 [email protected]
📞 +65 8912 8000
給我們留言